Compounds > omeprazole

omeprazole and albendazole

omeprazole has been researched along with albendazole in 14 studies

Research

Studies (14)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (21.43)	29.6817
2010's	8 (57.14)	24.3611
2020's	3 (21.43)	2.80

Authors

Authors	Studies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Castillo, R; Hernández-Campos, A; Hernández-Luis, F; Pérez-Villanueva, J; Romo-Mancillas, A; Yépez-Mulia, L	1
Freiwald, S; Jiang, Y; Jones, JP; Kaspera, R; Katayama, J; Lee, CA; Smith, E; Totah, RA; Walker, GS	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Bharate, SS; Vishwakarma, RA	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Hart, CJS; Riches, A; Skinner-Adams, TS; Trenholme, KR	1
Cortés-Benítez, F; Palacios-Espinosa, JF; Pérez-Villanueva, J; Rodríguez-Villar, K; Soria-Arteche, O; Yépez-Mulia, L	1
Gonzalez-Mendiola, R; Martínez Bohigas, D; Martínez Borque, N; Palomeque Rodríguez, T; Torrecillas Toro, M	1
Inkyo, M; Nagai, J; Nagata, S; Takano, M; Tanaka, Y; Yumoto, R	1
Castillo-Villanueva, A; de la Mora-de la Mora, I; Enríquez-Flores, S; Figueroa-Salazar, R; García-Torres, I; Gómez-Manzo, S; Gutiérrez-Castrellón, P; Hernández-Alcántara, G; López-Velázquez, G; Marcial-Quino, J; Méndez, ST; Oria-Hernández, J; Reyes-Vivas, H; Torres-Arroyo, A; Vanoye-Carlo, A; Yépez-Mulia, L	1
Caballero-Salazar, S; De la Mora-De la Mora, I; Enríquez-Flores, S; García-Torres, I; Hernández-Alcántara, G; López-Velázquez, G; Molina-Ortiz, D; Nava, G; Olivos-García, A	1
Ali, OT; Almalki, AJ; Hassan, WS; Khayyat, AN; Sebaiy, MM	1

Reviews

2 review(s) available for omeprazole and albendazole

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Anti- Journal of medicinal chemistry, 2020, 11-25, Volume: 63, Issue:22 Topics: Animals; Antiprotozoal Agents; Benzimidazoles; Drug Delivery Systems; Drug Discovery; Drug Therapy, Combination; Gastrointestinal Tract; Giardia; Giardiasis; Humans; Nitroimidazoles	2020

Other Studies

12 other study(ies) available for omeprazole and albendazole

Article	Year
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Antiprotozoal activity of proton-pump inhibitors. Bioorganic & medicinal chemistry letters, 2011, Dec-15, Volume: 21, Issue:24 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antiprotozoal Agents; Drug Design; Entamoeba histolytica; Giardia lamblia; Humans; Lansoprazole; Omeprazole; Pantoprazole; Parasitic Diseases; Proton Pump Inhibitors; Rabeprazole; Trichomonas vaginalis	2011
Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:5 Topics: Amiodarone; Astemizole; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Danazol; Drug Discovery; Drug Interactions; Enzyme Inhibitors; Humans; Hydroxylation; In Vitro Techniques; Methylation; Microsomes, Liver; Models, Biological; Molecular Structure; Substrate Specificity; Tandem Mass Spectrometry; Terfenadine	2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery. Bioorganic & medicinal chemistry letters, 2015, Apr-01, Volume: 25, Issue:7 Topics: Drug Discovery; Pharmaceutical Preparations; Solubility; Thermodynamics	2015
The giardicidal activity of lobendazole, fabomotizole, tenatoprazole and ipriflavone: A ligand-based virtual screening and in vitro study. European journal of medicinal chemistry, 2021, Feb-05, Volume: 211 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antiprotozoal Agents; Benzimidazoles; Carbamates; Humans; In Vitro Techniques; Isoflavones; Ligands	2021
Type I allergic reaction to benzimidazole antihelmintics. Allergy, 2007, Volume: 62, Issue:6 Topics: Albendazole; Anthelmintics; Benzimidazoles; Drug Hypersensitivity; Female; Humans; Mebendazole; Middle Aged; Omeprazole; Skin Tests	2007
Nanoparticulation of poorly water soluble drugs using a wet-mill process and physicochemical properties of the nanopowders. Chemical & pharmaceutical bulletin, 2009, Volume: 57, Issue:10 Topics: Albendazole; Anti-Ulcer Agents; Antiprotozoal Agents; Calorimetry, Differential Scanning; Danazol; Drug Compounding; Estrogen Antagonists; Freeze Drying; Nanoparticles; Omeprazole; Particle Size; Pharmaceutical Preparations; Poloxamer; Powders; Solubility; Surface-Active Agents; Temperature; Water; X-Ray Diffraction	2009
Giardial triosephosphate isomerase as possible target of the cytotoxic effect of omeprazole in Giardia lamblia. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:12 Topics: Albendazole; Antiprotozoal Agents; Axenic Culture; Cysteine; Dose-Response Relationship, Drug; Drug Resistance; Enzyme Inhibitors; Escherichia coli; Gene Expression; Giardia lamblia; Humans; Metronidazole; Mutation; Nitro Compounds; Omeprazole; Parasitic Sensitivity Tests; Protozoan Proteins; Recombinant Proteins; Spectrometry, Fluorescence; Thiazoles; Triose-Phosphate Isomerase; Trophozoites	2014
First characterization of a microsporidial triosephosphate isomerase and the biochemical mechanisms of its inactivation to propose a new druggable target. Scientific reports, 2018, 06-05, Volume: 8, Issue:1 Topics: Albendazole; Amino Acid Sequence; Encephalitozoon; Fungal Proteins; Gastrointestinal Diseases; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Fungal; Humans; Microsporidia; Microsporidiosis; Omeprazole; Rabeprazole; Sequence Homology, Amino Acid; Thiamine; Triose-Phosphate Isomerase	2018
HPLC Determination of Imidazoles with Variant Anti-Infective Activity in Their Dosage Forms and Human Plasma. Molecules (Basel, Switzerland), 2020, Dec-30, Volume: 26, Issue:1 Topics: Albendazole; Anti-Infective Agents; Calibration; Chemistry Techniques, Analytical; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Dosage Forms; Fenbendazole; Humans; Hydrogen-Ion Concentration; Imidazoles; Metronidazole; Omeprazole; Patient Safety; Reproducibility of Results; Solvents; Temperature; Ultraviolet Rays; United States; United States Food and Drug Administration	2020